30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Healthcare Sector Insider Trading Activity

Track insider buying and selling in Healthcare stocks. See which executives are buying, net insider activity, and % of float traded across 3,186 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
DE Sartorius AG (SRT)
Healthcare Services Large (13.7bn) 0 No activity — 50%+
US DaVita Inc (DVA)
Healthcare Services Large (13.7bn) -6–10 -$100M+ -0–15% 50%+
Pharmaceuticals & Medical Research Large (13.5bn) 0 No activity — 50%+
Healthcare Services Large (13.5bn) 0 No activity — 15–50%
US Exelixis Inc (EXEL)
Pharmaceuticals & Medical Research Large (13.4bn) -6–10 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (13.3bn) -1–5 -$100M+ -15–50% 0–15%
Pharmaceuticals & Medical Research Large (13.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.9bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (12.9bn) 0 No activity — 50%+
Healthcare Services Large (12.9bn) 0 No activity — 15–50%
Healthcare Services Large (12.9bn) 0 No activity — 15–50%
US Penumbra Inc (PEN)
Healthcare Services Large (12.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.7bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (12.6bn) -1–5 -$1M–$10M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (12.6bn) 0 No activity — 0–15%
Healthcare Services Large (12.5bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (12.3bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (12.1bn) -1–5 -$100K–$1M -0–15% 0–15%
US MyoKardia Inc (MYOK)
Pharmaceuticals & Medical Research Large (12.0bn) 0 No activity — 0–15%
Healthcare Services Large (11.7bn) 0 No activity — 0–15%
Healthcare Services Large (11.7bn) 0 No activity — 0–15%
Healthcare Services Large (11.6bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (11.5bn) -1–5 -$100K–$1M -0–15% 0–15%
US Catalent Inc (CTLT)
Pharmaceuticals & Medical Research Large (11.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (11.5bn) 0 No activity — 50%+
FI Orion Oyj (ORNBV)
Pharmaceuticals & Medical Research Large (11.2bn) 0 No activity — 0–15%
US Revvity Inc (RVTY)
Healthcare Services Large (11.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) 1–5 $100M+ 0–15% 50%+
Pharmaceuticals & Medical Research Large (10.9bn) -6–10 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (10.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (10.6bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (10.5bn) -1–5 -$1M–$10M -0–15% 0–15%
AU Cochlear Ltd (COH)
Healthcare Services Large (10.1bn) 0 No activity — 0–15%
US Insulet Corp (PODD)
Healthcare Services Large (10.1bn) 1–5 $100K–$1M 0–15% 0–15%
Healthcare Services Mid (10.0bn) -1–5 -$1M–$10M -0–15% 0–15%
FR Abivax SA (ABVX)
Pharmaceuticals & Medical Research Mid (9.8bn) 0 No activity — 0–15%
US Nuvalent Inc (NUVL)
Pharmaceuticals & Medical Research Mid (9.8bn) 0 No activity — 0–15%
Healthcare Services Mid (9.6bn) 0 No activity — 0–15%
Healthcare Services Mid (9.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (9.6bn) 0 No activity — 15–50%
US Masimo Corp (MASI)
Healthcare Services Mid (9.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (9.3bn) -6–10 -$1M–$10M -0–15% 15–50%
Healthcare Services Mid (9.3bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (9.1bn) 0 No activity — 0–15%
Healthcare Services Mid (8.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (8.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (8.9bn) 0 No activity — 0–15%
IE ICON PLC (ICLR)
Pharmaceuticals & Medical Research Mid (8.9bn) 0 No activity — 0–15%
IE Alkermes Plc (ALKS)
Pharmaceuticals & Medical Research Mid (8.8bn) -1–5 -$100K–$1M -0–15% 0–15%
US ImmunoGen Inc (IMGN)
Pharmaceuticals & Medical Research Mid (8.7bn) 0 No activity — 0–15%
US Bruker Corp (BRKR)
Healthcare Services Mid (8.7bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (8.6bn) 0 No activity — 0–15%
US Mylan NV (MYL)
Pharmaceuticals & Medical Research Mid (8.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (8.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (8.2bn) -1–5 -$100M+ -0–15% 0–15%
Healthcare Services Mid (8.2bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (8.2bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (8.1bn) 0 No activity — 0–15%
DK Demant A/S (DEMANT)
Healthcare Services Mid (8.1bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (8.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (8.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (7.9bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (7.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (7.9bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (7.8bn) -6–10 -$10M–$100M -0–15% 50%+
US Repligen Corp (RGEN)
Healthcare Services Mid (7.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (7.7bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (7.7bn) -1–5 -$1M–$10M -0–15% 0–15%
ES Grifols SA (GRF)
Pharmaceuticals & Medical Research Mid (7.6bn) 0 No activity — 15–50%
US Glaukos Corp (GKOS)
Healthcare Services Mid (7.4bn) -1–5 -$1M–$10M -0–15% 0–15%
IN Aurobindo Pharma Ltd (AUROPHARMA)
Pharmaceuticals & Medical Research Mid (7.4bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (7.2bn) -1–5 -$100K–$1M -0–15% 0–15%
US Vaxcyte Inc (PCVX)
Pharmaceuticals & Medical Research Mid (7.2bn) 0 No activity — 0–15%
Healthcare Services Mid (7.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (7.1bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (7.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (7.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — 50%+
US Merus NV (MRUS)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — 50%+
NL Qiagen NV (QIA)
Pharmaceuticals & Medical Research Mid (6.8bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.8bn) -1–5 -$1M–$10M -0–15% 0–15%
US Medicines Co (MDCO)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — —
US Arcellx Inc (ACLX)
Pharmaceuticals & Medical Research Mid (6.7bn) 0 No activity — 0–15%
US Liquidia Corp (LQDA)
Pharmaceuticals & Medical Research Mid (6.7bn) -1–5 -$100M+ -0–15% 0–15%
Healthcare Services Mid (6.4bn) 0 No activity — 50%+
SE Sectra AB (SECT-B)
Healthcare Services Mid (6.4bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (6.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.2bn) 0 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.1bn) -1–5 -< $100K -0–15% 0–15%
US R1 RCM Inc (RCM)
Healthcare Services Mid (6.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.9bn) -1–5 -$1M–$10M -0–15% 0–15%
US Chemed Corp (CHE)
Healthcare Services Mid (5.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.8bn) 0 No activity — 0–15%
US Teleflex Inc (TFX)
Healthcare Services Mid (5.8bn) 0 No activity — 0–15%
Healthcare Services Mid (5.8bn) -1–5 -$10M–$100M -0–15% 0–15%